KEYNOTE-A18 trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

KEYNOTE-A18 trial

Jan 2, 2025, 16:54 | Insight

Gustavo Viani: Top 10 clinical trials of 2024 that are reshaping how we treat cancer

Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, shared a post on…

Apr 24, 2024, 09:58 | Insight

KEYNOTE-A18 summarised by Sergio Cifuentes

Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on X/Twitter: ''KEYNOTE-A18. Pembrolizumab + CRT…

Jan 17, 2024, 19:34 | Drugs

Yüksel Ürün: The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer

Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023